Case Disclosed

Even for its strongest advocates and those who regularly exercise the rights it grants, the Freedom of Information Act is often reduced to its most-invoked provision: the obligation of federal agencies to produce specific records in response to requests.

Several news outlets have spoken out about President Trump for calling on only conservative and conservative leaning news outlets in three joint news conferences with foreign leaders over the last few weeks.

President Trump has signaled—often and recently—that he believes drug approval moves too slowly. Meeting with drug manufacturers at the White House on Jan. 31, Trump promised quick yes-or-no approval decisions on new drugs (and stressed the need for lower prices and U.S.-based manufacturing). But the FDA moves fast already— fast enough, say some experts who worry about the standards used to move drugs through review pathways like Priority Review, Breakthrough Therapy, Accelerated Approval, and Fast Track. And when the president pushes for even less rigor, these questions become even more

Canada’s public health department, Health Canada, is preparing to release its final guidance on the section of Vanessa’s Law designed to promote the transparency of information around pharmaceutical drugs.

This year has seen a remarkable string of disclosures about national security letters (NSLs), the secret demands the FBI sends to financial and communications service providers compelling the disclosure of customer information and transactional data.

This post’s focus is on lethal injection access litigation that the Clinic has been carrying out in Missouri on behalf of five national and state news organizations.